The role of interleukins in pathogenesis and prognosis of atrial fibrillation

References

• Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017 Apr 28;120(9):1501–1517.
   PubMed Web of Science ®Google Scholar
• Lozano-Velasco E, Franco D, Aranega A, et al. Genetics and epigenetics of atrial fibrillation. Int J Mol Sci. 2020 Aug 10;21:(16):5717.
   PubMed Web of Science ®Google Scholar
• Chen J, Mei Z, Yang Y, et al. Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2022 Jun 11;22(1):264.
   PubMed Web of Science ®Google Scholar
• Shetty SS, Krumerman A. Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions. Cardiovasc Diabetol. 2022 Jun 28;21(1):119.
   PubMed Web of Science ®Google Scholar
• Yang TY, Huang L, Malwade S, et al. Diagnostic accuracy of ambulatory devices in detecting atrial fibrillation: systematic review and meta-analysis. JMIR mHealth uHealth. 2021 Apr 9;9(4):e26167.
   PubMed Web of Science ®Google Scholar
• Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clin Cardiol. 2017 Jun;40(6):413–418.
   PubMed Web of Science ®Google Scholar
• Gutierrez C, Blanchard DG. Atrial fibrillation: diagnosis and treatment. Am Fam Physician. 2011 Jan 1;83(1):61–68.
   PubMed Web of Science ®Google Scholar
• Li J, Gao M, Zhang M, et al. Treatment of atrial fibrillation: a comprehensive review and practice guide. Cardiovasc J Afr. 2020 May 23;31(3):153–158.
   PubMed Web of Science ®Google Scholar
• Isaksen JL, Baumert M, Hermans ANL, et al. Artificial intelligence for the detection, prediction, and management of atrial fibrillation. Herzschrittmacherther Elektrophysiol. 2022 Mar;33(1):34–41.
   PubMedGoogle Scholar
• Sánchez FJ, Pueyo E, Diez ER. Strain echocardiography to predict postoperative atrial fibrillation. Int J Mol Sci. 2022 Jan 25;23(3):1355.
   PubMed Web of Science ®Google Scholar
• Wolfes J, Ellermann C, Frommeyer G, et al.Evidence-based treatment of atrial fibrillation around the globe: comparison of the latest ESC, AHA/ACC/HRS, and CCS guidelines on the management of atrial fibrillationRev Cardiovasc Med. 2022 Feb; 1123256
   PubMed Web of Science ®Google Scholar
• Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020 Jan;106(1):10–17.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Naccarelli GV, Mittal S, et al. The increasing role of rhythm control in patients with atrial fibrillation: jACC state-of-the-art review. J Am Coll Cardiol. 2022 May 17;79(19):1932–1948.
   PubMed Web of Science ®Google Scholar
• Vonderlin N, Siebermair J, Kaya E, et al. Critical inflammatory mechanisms underlying arrhythmias. Herz. 2019 Apr;44(2):121–129.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu M, Chen X. Identification of potential key biomarkers of atrial fibrillation and their correlation with immune infiltration in atrial tissue. Comput Math Methods Med. 2022;2022:4029840.
   PubMed Web of Science ®Google Scholar
• Bruins P, Te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997 Nov 18;96(10):3542–3548.
   PubMed Web of Science ®Google Scholar
• Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001 Dec 11;104(24):2886–2891.
   PubMed Web of Science ®Google Scholar
• Zhou P, Waresi M, Zhao Y, et al. Increased serum interleukin-6 level as a predictive biomarker for atrial fibrillation: A systematic review and meta-analysis. Rev Port Cardiol (Engl Ed). 2020;39(12):723–728.
   PubMed Web of Science ®Google Scholar
• Chang G, Chen Y, Liu Z, et al. The PD-1 with PD-L1 axis is pertinent with the immune modulation of atrial fibrillation by regulating T cell excitation and promoting the secretion of inflammatory factors. J Immunol Res. 2022;2022:3647817.
   PubMed Web of Science ®Google Scholar
• Jia X, Cheng X, Wu N, et al. Prognostic value of interleukin-6 in atrial fibrillation: a cohort study and meta-analysis. Anatol J Cardiol. 2021 Dec;25(12):872–879.
   PubMed Web of Science ®Google Scholar
• Tilly MJ, Geurts S, Donkel SJ, et al. Immunothrombosis and new-onset atrial fibrillation in the general population: the Rotterdam study. Clin Res Cardiol. 2022 Jan;111(1):96–104.
   PubMed Web of Science ®Google Scholar
• Sveen KA, Smith G, Björkbacka H, et al. High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women. J Intern Med. 2022 Feb;291(2):207–217.
   PubMed Web of Science ®Google Scholar
• Zhang D, Ma Y, Xu J, et al. Association between obstructive sleep apnea (OSA) and atrial fibrillation (AF): a dose-response meta-analysis. Medicine (Baltimore). 2022 Jul 29;101(30):e29443.
   PubMed Web of Science ®Google Scholar
• Andrade J, Khairy P, Dobrev D, et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014 Apr 25;114(9):1453–1468.
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet. 2015 Jul 11;386(9989):154–162.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2020 Feb 1;42(5):373–498.
   Web of Science ®Google Scholar
• Baroutidou A, Kartas A, Samaras A, et al. Associations of atrial fibrillation patterns with mortality and cardiovascular events: implications of the MISOAC-AF Trial. J Cardiovasc Pharmacol Ther. 2022 Jan;27:10742484211069422.
   Web of Science ®Google Scholar
• Sairenchi T, Yamagishi K, Iso H, et al. Atrial fibrillation with and without cardiovascular risk factors and stroke mortality. J Atheroscler Thromb. 2021 Mar 1;28(3):241–248.
   PubMed Web of Science ®Google Scholar
• Blum S, Aeschbacher S, Coslovsky M, et al. Long-term risk of adverse outcomes according to atrial fibrillation type. Sci Rep. 2022 Feb 9;12(1):2208.
   PubMed Web of Science ®Google Scholar
• Romero I, Nedios S, Kriatselis C. Diagnosis and management of atrial fibrillation: an overview. Cardiovasc Ther. 2014 Oct;32(5):242–252.
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991 Aug;22(8):983–988.
   PubMed Web of Science ®Google Scholar
• Maduray K, Moneruzzaman M, Changwe GJ, et al. Benefits and risks associated with long-term oral anticoagulation after successful atrial fibrillation catheter ablation: systematic review and meta-analysis. Clin Appl Thromb Hemost. 2022 Jan;28:10760296221118480.
   Web of Science ®Google Scholar
• Ogawa H, Akao M. Is progression from paroxysmal to sustained atrial fibrillation bad news? Circ J. 2022 Jan 25;86(2):176–181.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Wachter R, Schmalstieg-Bahr K, et al. Screening for atrial fibrillation in the older population: a randomized clinical trial. JAMA Cardiol. 2021 May 1;6(5):558–567.
   PubMed Web of Science ®Google Scholar
• Gurp N VV, Uittenbogaart SB, Lucassen WAM, et al. Detection of atrial fibrillation in primary care with radial pulse palpation, electronic blood pressure measurement and handheld single-lead electrocardiography: a diagnostic accuracy study. BMJ Open. 2022 Jun 29;12(6):e059172.
   PubMed Web of Science ®Google Scholar
• Fuster V, Rydén LE, Cannom DS, et al. ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2011 [2011 Mar 15];123(10):e269–367.
   PubMed Web of Science ®Google Scholar
• Scott L Jr., Li N, Dobrev D. Role of inflammatory signaling in atrial fibrillation. Int J Cardiol. 2019 Jul 15;287:195–200.
   PubMed Web of Science ®Google Scholar
• Li X, Garcia-Elias A, Benito B, et al. The effects of cardiac stretch on atrial fibroblasts: analysis of the evidence and potential role in atrial fibrillation. Cardiovasc Res. 2022 Jan 29;118(2):440–460.
   PubMed Web of Science ®Google Scholar
• Manoharan A, Sambandam R, Ballambattu VB. Genetics of atrial fibrillation-an update of recent findings. Mol Biol Rep. 2022 Aug;49(8):8121–8129.
   PubMed Web of Science ®Google Scholar
• Roselli C, Chaffin MD, Weng LC, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018 Jun 11;50(9):1225–1233.
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Ito K, Ito M, et al. Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nat Genet.2023 Jan 19;55:187–197.
   PubMedGoogle Scholar
• Zhang J, Huang X, Wang X, et al. Identification of potential crucial genes in atrial fibrillation: a bioinformatic analysis. BMC Med Genomics. 2020 Jul 18;13(1):104.
   PubMed Web of Science ®Google Scholar
• Nielsen JB, Thorolfsdottir RB, Fritsche LG, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018 Sep;50(9):1234–1239.
   PubMed Web of Science ®Google Scholar
• Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003 Dec 16;108(24):3006–3010.
   PubMed Web of Science ®Google Scholar
• Polak-Szczybyło E, Tabarkiewicz J. IL-17A, IL-17E and IL-17F as potential biomarkers for the intensity of low-grade inflammation and the risk of cardiovascular diseases in obese people. Nutrients. 2022 Feb 2;14(3):643.
   PubMed Web of Science ®Google Scholar
• Zhuang YG, Chen YZ, Zhou SQ, et al. High plasma levels of pro-inflammatory factors interleukin-17 and interleukin-23 are associated with poor outcome of cardiac-arrest patients: a single center experience. BMC Cardiovasc Disord. 2020 Apr 15;20(1):170.
   PubMed Web of Science ®Google Scholar
• Silvain J, Kerneis M, Zeitouni M, et al. Interleukin-1β and risk of premature death in patients with myocardial infarction. J Am Coll Cardiol. 2020 Oct 13;76(15):1763–1773.
   PubMed Web of Science ®Google Scholar
• Lechner I, Reindl M, Tiller C, et al. Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction. Int J Cardiol. 2022 Aug 15;361:1–6.
   PubMed Web of Science ®Google Scholar
• Bro-Jeppesen J, Kjaergaard J, Stammet P, et al. Predictive value of interleukin-6 in post-cardiac arrest patients treated with targeted temperature management at 33 °C or 36 °C. Resuscitation. 2016 Jan;98:1–8.
   PubMed Web of Science ®Google Scholar
• Bro-Jeppesen J, Kjaergaard J, Wanscher M, et al. Systemic inflammatory response and potential prognostic implications after out-of-hospital cardiac arrest: a substudy of the target temperature management trial. Crit Care Med. 2015 Jun;43(6):1223–1232.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang Y, Xiao Y, et al. Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases. Sci Rep. 2022 Jan 20;12(1):1075.
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Cantara S, Bertolozzi I, et al. Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men. J Am Heart Assoc. 2022 Jan 4;11(1):e023371.
   PubMed Web of Science ®Google Scholar
• Feng X, Wu F, Wu Y, et al. A prediction rule including interleukin-6 in pericardial drainage improves prediction of new-onset atrial fibrillation after coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2022 Jul;36(7):1975–1984.
   PubMed Web of Science ®Google Scholar
• Weymann A, Popov AF, Sabashnikov A, et al. Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis. Kardiol Pol. 2018;76(2):440–451.
   PubMed Web of Science ®Google Scholar
• Wu ZK, Laurikka J, Vikman S, et al. High postoperative interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgery. World J Surg. 2008 Dec;32(12):2643–2649.
   PubMed Web of Science ®Google Scholar
• Wu Q, Liu H, Liao J, et al. Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model. Biomed Pharmacother Biomed Pharmacother. 2020 Sep;129:110384.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu F, Wu Y, et al. Mechanism of IL-6-related spontaneous atrial fibrillation after coronary artery grafting surgery: iL-6 knockout mouse study and human observation. Transl Res. 2021 Jul;233:16–31.
   PubMed Web of Science ®Google Scholar
• Dobrev D, Aguilar M, Heijman J, et al. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol. 2019 Jul;16(7):417–436.
   PubMed Web of Science ®Google Scholar
• Huang Z, Chen XJ, Qian C, et al. Signal transducer and activator of transcription 3/MicroRNA-21 feedback loop contributes to atrial fibrillation by promoting atrial fibrosis in a rat sterile pericarditis model. Circ Arrhythm Electrophysiol. 2016 Jul;9(7):e003396.
   PubMed Web of Science ®Google Scholar
• Mitrokhin VM, Mladenov MI, Kamkin AG. Effects of interleukin-6 on the bio-electric activity of rat atrial tissue under normal conditions and during gradual stretching. Immunobiology. 2015 Sep;220(9):1107–1112.
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Laghi-Pasini F, Acampa M, et al. Systemic inflammation rapidly induces reversible atrial electrical remodeling: the role of interleukin-6-mediated changes in connexin expression. J Am Heart Assoc. 2019 Aug 20;8(16):e011006.
   PubMed Web of Science ®Google Scholar
• Liao J, Zhang S, Yang S, et al. Interleukin-6-mediated-Ca(2+) handling abnormalities contributes to atrial fibrillation in sterile pericarditis rats. Front Immunol. 2021;12:758157.
   PubMed Web of Science ®Google Scholar
• Nikoo MH, Taghavian SR, Golmoghaddam H, et al. Increased IL-17A in atrial fibrillation correlates with neutrophil to lymphocyte ratio. Iran J Immunol. 2014 Dec;11(4):246–258.
   PubMed Web of Science ®Google Scholar
• Mirza M, Caracciolo G, Khan U, et al. Left atrial reservoir function predicts atrial fibrillation recurrence after catheter ablation: a two-dimensional speckle strain study. J Interv Card Electrophysiol. 2011 Sep;31(3):197–206.
   PubMed Web of Science ®Google Scholar
• Xu L, Wang N, Liang Y, et al. Interleukin-17A contributes to atrial fibrillation recurrence and left atrial reservoir function after catheter ablation. Pol Arch Intern Med. 2019 Jun 28;129(6):432–435.
   PubMedGoogle Scholar
• Xu L, Fan T, Liang Y, et al. Association between interleukin 17A levels and left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation. Pol Arch Intern Med. 2022 Jun 29;132:(6):16252.
   PubMedGoogle Scholar
• Ajoolabady A, Nattel S, Lip GYH, et al. Inflammasome Signaling in atrial fibrillation: jACC state-of-the-art review. J Am Coll Cardiol. 2022 Jun 14;79(23):2349–2366.
   PubMed Web of Science ®Google Scholar
• Yao C, Veleva T, Scott L Jr., et al.Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillationCirculation. 2018Nov 13138202227–2242
   PubMed Web of Science ®Google Scholar
• Li N, Brundel B. Inflammasomes and proteostasis novel molecular mechanisms associated with atrial fibrillation. Circ Res. 2020 Jun 19;127(1):73–90.
   PubMed Web of Science ®Google Scholar
• Guo WH, Wang X, Shang MS, et al. Crosstalk between PKC and MAPK pathway activation in cardiac fibroblasts in a rat model of atrial fibrillation. Biotechnol Lett. 2020 Jul;42(7):1219–1227.
   PubMed Web of Science ®Google Scholar
• Zhang D, Chen X, Wang Q, et al. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation. PLoS ONE. 2017;12(3):e0173759.
   PubMed Web of Science ®Google Scholar
• Liu Y, Luo D, Liu E, et al. MiRNA21 and IL-18 levels in left atrial blood in patients with atrial fibrillation undergoing cryoablation and their predictive value for recurrence of atrial fibrillation. J Interv Card Electrophysiol. 2022 Jun;64(1):111–120.
   PubMed Web of Science ®Google Scholar
• Yin G, Ma B, Zhou B, et al. Inflammatory response after different ablation strategies for paroxysmal atrial fibrillation. Heart Surg Forum. 2020 Sep 29;23(5):E703–e711.
   PubMed Web of Science ®Google Scholar
• Zhou H, Lin S, Li X, et al. Serum miR-222 is independently associated with atrial fibrillation in patients with degenerative valvular heart disease. BMC Cardiovasc Disord. 2021 Feb 16;21(1):98.
   PubMed Web of Science ®Google Scholar
• Jiang S, Guo C, Zhang W, et al. The integrative regulatory network of circRNA, microRNA, and mRNA in atrial fibrillation. Front Genet. 2019;10:526.
   PubMed Web of Science ®Google Scholar
• Karam BS, Chavez-Moreno A, Koh W, et al. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017 Sep 29;16(1):120.
   PubMedGoogle Scholar
• Mahajan R, Lau DH, Brooks AG, et al. Atrial fibrillation and obesity: reverse remodeling of atrial substrate with weight reduction. JACC Clin Electrophysiol. 2021 May;7(5):630–641.
   PubMedGoogle Scholar
• Role of Exosomes Derived From Epicardial Fat in Atrial Fibrillation [updated April 8, 2021;March 27, 2018]. Available from: https://clinicaltrials.gov/ct2/show/NCT03478410
   Google Scholar
• Shaihov-Teper O, Ram E, Ballan N, et al. Extracellular vesicles from epicardial fat facilitate atrial fibrillation. Circulation. 2021 Jun 22;143(25):2475–2493.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Kelesoglu S, Elcik D, et al. Predictive values of systemic immune-inflammation index in new-onset atrial fibrillation following coronary artery bypass grafting. Braz J Cardiovasc Surg. 2022 Jun 3;38(1): 96–103.
   PubMed Web of Science ®Google Scholar
• Topal D, Korkmaz UTK, Velioglu Y, et al. Systemic immune-inflammation index as a novel predictor of atrial fibrillation after off-pump coronary artery bypass grafting. Rev Assoc Med Bras (1992). 2022 Sep;68(9):1240–1246.
   PubMed Web of Science ®Google Scholar
• Kuş G, Çağırcı G, Bayar N, et al. Usefulness of the systemic immune-inflammation index in predicting atrial fibrillation recurrence after direct current cardioversion. Biomarker Med. 2022 Aug;16(11):847–855.
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhang J, Liu T, et al. The systemic-immune-inflammation index predicts the recurrence of atrial fibrillation after cryomaze concomitant with mitral valve surgery. BMC Cardiovasc Disord. 2022 Feb 13;22(1):45.
   PubMed Web of Science ®Google Scholar
• Wang J, Hu S, Liang C, et al. The association between systemic inflammatory response index and new-onset atrial fibrillation in patients with ST-elevated myocardial infarction treated with percutaneous coronary intervention. BMC Cardiovasc Disord. 2022 Dec 6;22(1):525.
   PubMed Web of Science ®Google Scholar
• Bağcı A, Aksoy F. Systemic immune-inflammation index predicts new-onset atrial fibrillation after ST elevation myocardial infarction. Biomarker Med. 2021 Jun;15(10):731–739.
   PubMed Web of Science ®Google Scholar
• Lin KB, Fan FH, Cai MQ, et al. Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res. 2022 Jul 2;27(1):106.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D’agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998 Sep 8;98(10):946–952.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014 Jan;174(1):107–114.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016 [2016 Oct 7];37(38):2893–2962.
   PubMed Web of Science ®Google Scholar
• Hijazi Z, Oldgren J, Andersson U, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy. Circulation. 2012 Apr 3;125(13):1605–1616.
   PubMed Web of Science ®Google Scholar
• Sharma A, Hijazi Z, Andersson U, et al.Use of biomarkers to predict specific causes of death in patients with atrial fibrillationCirculation 2018 Oct 16138161666–1676
   PubMed Web of Science ®Google Scholar
• Conway DS, Buggins P, Hughes E, et al. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol. 2004 Aug 15;94(4):508–510.
   PubMed Web of Science ®Google Scholar
• Loricchio ML, Cianfrocca C, Pasceri V, et al. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol. 2007 May 15;99(10):1421–1424.
   PubMed Web of Science ®Google Scholar
• Huang J, Wu N, Xiang Y, et al. Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation. Int J Cardiol. 2020 Dec 1;320:83–89.
   PubMed Web of Science ®Google Scholar
• Karaliūtė R, Leleika A, Apanavičiūtė I, et al. Risk factors of early atrial fibrillation recurrence following electrical cardioversion when left ventricular ejection fraction is preserved. Med (Kaunas). 2022 Aug 4;58:(8):1053.
   PubMed Web of Science ®Google Scholar
• Pol T, Hijazi Z, Lindbäck J, et al. Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation. Cardiovasc Res. 2022 Jul 20;118(9):2112–2123.
   PubMed Web of Science ®Google Scholar
• Aulin J, Hijazi Z, Lindbäck J, et al. Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model. Am Heart J. 2022 Sep;251:13–24.
   PubMed Web of Science ®Google Scholar
• Aulin J, Siegbahn A, Hijazi Z, et al. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J. 2015 Dec;170(6):1151–1160.
   PubMed Web of Science ®Google Scholar
• Ziegler L, Wallén H, Aspberg S, et al. IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation. BMC neurol. 2021 Aug 9;21(1):306.
   PubMed Web of Science ®Google Scholar
• Aulin J, Hijazi Z, Siegbahn A, et al. Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: insights from ARISTOTLE and RE-LY trials. J Thromb Haemost. 2020 Sep;18(9):2287–2295.
   PubMed Web of Science ®Google Scholar
• Leung DY, Black IW, Cranney GB, et al. Selection of patients for transesophageal echocardiography after stroke and systemic embolic events. Role of transthoracic echocardiography. Stroke. 1995 Oct;26(10):1820–1824.
   PubMed Web of Science ®Google Scholar
• Singleton MJ, Yuan Y, Dawood FZ, et al. Multiple blood biomarkers and stroke risk in atrial fibrillation: the REGARDS study. J Am Heart Assoc. 2021 Aug 3;10(15):e020157.
   PubMed Web of Science ®Google Scholar
• Rigopoulos AG, Kalogeropoulos AS, Tsoporis JN, et al. Heat shock protein 70 is associated with cardioversion outcome and recurrence of symptomatic recent onset atrial fibrillation in hypertensive patients. J Cardiovasc Pharmacol. 2021 Mar 1;77(3):360–369.
   PubMed Web of Science ®Google Scholar
• Yuan S, Lin A, He QQ, et al. Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: a two-sample Mendelian randomization study. Int J Cardiol. 2020 Aug 15;313:99–104.
   PubMed Web of Science ®Google Scholar
• Ząbczyk MT, Hanarz M, Malinowski KP, et al. Active FXI can independently predict ischemic stroke in anticoagulated atrial fibrillation patients: a cohort study. Thromb Haemost. 2022 Aug;122(8):1397–1406.
   PubMedGoogle Scholar
• Wu N, Chen X, Cai T, et al. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis. Can J Cardiol. 2015 Mar;31(3):278–286.
   PubMed Web of Science ®Google Scholar
• Lip GY, Patel JV, Hughes E, et al. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke. 2007 Apr;38(4):1229–1237.
   PubMed Web of Science ®Google Scholar
• Guo Y, Lip GY, Apostolakis S. Inflammatory biomarkers and atrial fibrillation: potential role of inflammatory pathways in the pathogenesis of atrial fibrillation-induced thromboembolism. Curr Vasc Pharmacol. 2015;13(2):192–201.
   PubMed Web of Science ®Google Scholar
• Andrade JG, Khairy P, Verma A, et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012 Jan;35(1):106–116.
   PubMed Web of Science ®Google Scholar
• Lim HS, Schultz C, Dang J, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2014 Feb;7(1):83–89.
   PubMed Web of Science ®Google Scholar
• Robinson E, Kaushal S, Alaboson J, et al. Combinatorial release of dexamethasone and amiodarone from a nano-structured parylene-C film to reduce perioperative inflammation and atrial fibrillation. Nanoscale. 2016 Feb 21;8(7):4267–4275.
   PubMed Web of Science ®Google Scholar
• Horikoshi Y, Goyagi T, Kudo R, et al. The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: a randomized controlled clinical trial. J Clin Anesth. 2017 May;38:111–116.
   PubMed Web of Science ®Google Scholar
• Harb IA, Ashour H, Mostafa A, et al. Cardioprotective effects of amiodarone in a rat model of epilepsy-induced cardiac dysfunction. Clin Exp Pharmacol Physiol. 2022 Mar;49(3):406–418.
   PubMed Web of Science ®Google Scholar
• Wu Y, Tan L, Shi L, et al. Interleukin-22 is elevated in the atrium and plasma of patients with atrial fibrillation and increases collagen synthesis in transforming growth factor-β1-treated cardiac fibroblasts via the JNK pathway. Exp Ther Med. 2020 Aug;20(2):1012–1020.
   PubMed Web of Science ®Google Scholar
• Li PF, He RH, Shi SB, et al. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation. Biosci Rep. 2019 Feb 28;39:(2):BSR20181931.
   PubMedGoogle Scholar
• Kondo H, Abe I, Gotoh K, et al. Interleukin 10 treatment ameliorates high-fat diet-induced inflammatory atrial remodeling and fibrillation. Circ Arrhythm Electrophysiol. 2018 May;11(5):e006040.
   PubMed Web of Science ®Google Scholar
• Deftereos S, Giannopoulos G, Kossyvakis C, et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol. 2012 Oct 30;60(18):1790–1796.
   PubMed Web of Science ®Google Scholar
• Tabbalat RA, Hamad NM, Alhaddad IA, et al. Effect of ColchiciNe on the InciDence of atrial fibrillation in open heart surgery patients: eND-AF trial. Am Heart J. 2016 Aug;178:102–107.
   PubMed Web of Science ®Google Scholar
• Use of colchicine to decrease atrial fibrillation recurrence after ablation [Jul 15, 2022]. Available from: https://clinicaltrials.gov/ct2/show/NCT05459974?term=interluekins+OR+cytokine+OR+CRP&recrs=ab&cond=Atrial+Fibrillation&draw=2&rank=4
   Google Scholar
• Liang Z, Shi XM, Liu LF, et al. Renal denervation suppresses atrial fibrillation in a model of renal impairment. PLoS ONE. 2015;10(4):e0124123.
   PubMed Web of Science ®Google Scholar
• Liu M, Li W, Wang H, et al. CTRP9 ameliorates atrial inflammation, fibrosis, and vulnerability to atrial fibrillation in post-myocardial infarction rats. J Am Heart Assoc. 2019 Nov 5;8(21):e013133.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang S, Liu Z, et al. Resveratrol prevents atrial fibrillation by inhibiting atrial structural and metabolic remodeling in collagen-induced arthritis rats. Naunyn Schmiedebergs Arch Pharmacol. 2018 Nov;391(11):1179–1190.
   PubMed Web of Science ®Google Scholar
• Hiram R, Xiong F, Naud P, et al. The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease. Cardiovasc Res. 2021 Jun 16;117(7):1776–1789.
   PubMed Web of Science ®Google Scholar
• Gronroos NN, Chamberlain AM, Folsom AR, et al. Fish, fish-derived n-3 fatty acids, and risk of incident atrial fibrillation in the atherosclerosis risk in communities (ARIC) study. PLoS ONE. 2012;7(5):e36686.
   PubMed Web of Science ®Google Scholar
• Wang H, Chen J, Zhao L. N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review. J Interv Card Electrophysiol. 2018 Mar;51(2):105–115.
   PubMed Web of Science ®Google Scholar
• Zuo K, Fang C, Liu Z, et al. Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling. Int J Biol Sci. 2022;18(10):4219–4232.
   PubMed Web of Science ®Google Scholar
• Hua F, Shi L, Zhou P. Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases. Inflammopharmacology. 2022 Feb;30(1):137–147.
   PubMed Web of Science ®Google Scholar
• Inflammatory and Endothelial Function Response, and arrhythmia recurrence following catheter ablation for atrial fibrillation [updated August 25, 2022; February 17, 2020]. Available from: https://clinicaltrials.gov/ct2/show/NCT04269785?term=interluekins+OR+cytokine+OR+CRP&recrs=ab&cond=Atrial+Fibrillation&draw=2&rank=7
   Google Scholar
• Colchicine and CRP in atrial fibrillation and AF ablation [updated May 9, 2019; December 24, 2012]. Available from: https://clinicaltrials.gov/ct2/show/NCT01755949?term=interleukins+OR+cytokine+OR+CRP&recrs=de&cond=Atrial+Fibrillation&draw=1&rank=2
   Google Scholar